BR0006899A - Detection of resistance to anti-hepatitis b drugs - Google Patents
Detection of resistance to anti-hepatitis b drugsInfo
- Publication number
- BR0006899A BR0006899A BR0006899-3A BR0006899A BR0006899A BR 0006899 A BR0006899 A BR 0006899A BR 0006899 A BR0006899 A BR 0006899A BR 0006899 A BR0006899 A BR 0006899A
- Authority
- BR
- Brazil
- Prior art keywords
- resistance
- drugs
- detection
- hbv
- hepatitis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
"DETECçãO DE RESISTêNCIA A MEDICAMENTOS ANTI-HEPATITE B" A presente invenção se refere a um processo para a monitoração de resistência a medicamentos anti-HBV em um paciente por detecção genética de pelo menos uma das mutações L528M, M552V/I e/ou V/L/M5551 na DNA polimerase das cepas de HBV presentes em uma amostra biológica do paciente. A presente invenção propõe novas seq³ências de DNA polimerase de HBV a serem usadas para a construção de novas sondas que permitem uma detecção muito específica e sensível de resistência a medicamentos anti-HBV."DETECTION OF RESISTANCE TO ANTI-HEPATITIS B DRUGS" The present invention relates to a process for monitoring resistance to anti-HBV drugs in a patient by genetic detection of at least one of the L528M, M552V / I and / or V mutations / L / M5551 in the DNA polymerase of HBV strains present in a biological sample from the patient. The present invention proposes new HBV DNA polymerase sequences to be used for the construction of new probes that allow a very specific and sensitive detection of resistance to anti-HBV drugs.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99870148 | 1999-07-08 | ||
US14354699P | 1999-07-13 | 1999-07-13 | |
PCT/EP2000/006306 WO2001004358A2 (en) | 1999-07-08 | 2000-07-05 | Detection of anti-hepatitis b drug resistance |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0006899A true BR0006899A (en) | 2001-06-12 |
Family
ID=30129296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0006899-3A BR0006899A (en) | 1999-07-08 | 2000-07-05 | Detection of resistance to anti-hepatitis b drugs |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1144693A3 (en) |
JP (1) | JP2003505021A (en) |
CN (1) | CN1384888A (en) |
AR (1) | AR028149A1 (en) |
AU (1) | AU6431700A (en) |
BR (1) | BR0006899A (en) |
CA (1) | CA2339422A1 (en) |
TR (2) | TR200100689T1 (en) |
WO (1) | WO2001004358A2 (en) |
ZA (1) | ZA200101680B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6583279B1 (en) * | 2001-01-26 | 2003-06-24 | Becton, Dickinson And Company | Sequences and methods for detection of hepatitis B virus |
GR1003878B (en) * | 2001-03-13 | 2002-04-24 | Γεωργακοπουλος Ελευθεριος Δρ. | Plastic vineyard-covering fabric |
AU2003253651C1 (en) | 2002-06-14 | 2010-06-03 | Gen-Probe Incorporated | Compositions and methods for detecting hepatitis B virus |
WO2004024095A2 (en) * | 2002-09-13 | 2004-03-25 | Idenix (Cayman) Limited | ß-L-2'-DEOXYNUCLEOSIDES FOR THE TREATMENT OF RESISTANT HBV STRAINS AND COMBINATION THERAPIES |
KR100650162B1 (en) * | 2003-08-05 | 2006-11-27 | 주식회사 진인 | Microarray comprising probes for drug-resistant hepatitis B virus detection, quality control and negative control, and Method for detecting drug-resistant hepatitis B virus using the same |
US20100292471A1 (en) * | 2006-12-18 | 2010-11-18 | Panagene Inc. | Peptide nucleic acid oligomers comprising universal bases,preparation methods thereof, and kits, devices and methods for the analysis, detection or modulation of nucleic acids using the same |
JP2008283977A (en) * | 2008-06-09 | 2008-11-27 | Toshiba Corp | Method for judging genotype and mutation of target nucleic acid, method for immobilizing nucleic acid fragment on insoluble substrate, method for refining and amplifying desired nucleic acid, and genotype assay kit |
CN101812537B (en) * | 2009-10-27 | 2012-08-08 | 重庆医科大学 | Method and reagent kit for simultaneously detecting resistance site of three nucleotide analogues of hepatitis B virus |
US9045803B2 (en) | 2012-02-29 | 2015-06-02 | Abbott Molecular Inc. | Hepatitis B virus typing and resistance assay |
CA3043637A1 (en) * | 2016-11-11 | 2018-05-17 | Janssen Biopharma, Inc. | Oligonucleotide targeting strategy for hbv cccdna |
CN109609694B (en) * | 2018-12-29 | 2022-03-01 | 上海昂朴生物科技有限公司 | Kit and method for detecting hepatitis B typing and multiple drug-resistant sites based on Illumina sequencing technology |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995002690A1 (en) * | 1993-07-13 | 1995-01-26 | Abbott Laboratories | Nucleotide sequences and process for amplifying and detection of hepatitis b virus |
US5667974A (en) * | 1995-06-07 | 1997-09-16 | Abbott Laboratories | Method for detecting nucleic acid sequences using competitive amplification |
ZA973367B (en) * | 1996-04-19 | 1997-11-18 | Innogenetics Nv | Method for typing and detecting HBV. |
AUPO351996A0 (en) * | 1996-11-08 | 1996-12-05 | Western Health Care Network | Viral variants and methods for detecting same |
-
2000
- 2000-07-03 AR ARP000103391A patent/AR028149A1/en unknown
- 2000-07-05 AU AU64317/00A patent/AU6431700A/en not_active Abandoned
- 2000-07-05 WO PCT/EP2000/006306 patent/WO2001004358A2/en not_active Application Discontinuation
- 2000-07-05 TR TR2001/00689T patent/TR200100689T1/en unknown
- 2000-07-05 JP JP2001509556A patent/JP2003505021A/en active Pending
- 2000-07-05 BR BR0006899-3A patent/BR0006899A/en not_active IP Right Cessation
- 2000-07-05 TR TR2002/01797T patent/TR200201797T1/en unknown
- 2000-07-05 EP EP00951337A patent/EP1144693A3/en not_active Withdrawn
- 2000-07-05 CA CA002339422A patent/CA2339422A1/en not_active Abandoned
- 2000-07-05 CN CN00801329A patent/CN1384888A/en active Pending
-
2001
- 2001-02-28 ZA ZA200101680A patent/ZA200101680B/en unknown
Also Published As
Publication number | Publication date |
---|---|
TR200201797T1 (en) | 2003-05-21 |
ZA200101680B (en) | 2003-05-28 |
AU6431700A (en) | 2001-01-30 |
TR200100689T1 (en) | 2002-04-22 |
JP2003505021A (en) | 2003-02-12 |
WO2001004358A2 (en) | 2001-01-18 |
WO2001004358A3 (en) | 2001-08-30 |
CA2339422A1 (en) | 2001-01-18 |
CN1384888A (en) | 2002-12-11 |
EP1144693A3 (en) | 2001-11-28 |
AR028149A1 (en) | 2003-04-30 |
EP1144693A2 (en) | 2001-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2298244T5 (en) | Method for the detection of influenza A / B viruses in saliva | |
BR0006899A (en) | Detection of resistance to anti-hepatitis b drugs | |
Jardi et al. | Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants | |
Fujioka et al. | Molecular detection and differentiation of enteroviruses in endomyocardial biopsies and pericardial effusions from dilated cardiomyopathy and myocarditis | |
GB8423659D0 (en) | Cloned dna sequences | |
WO2002040717A3 (en) | In vitro cell-based methods for biological validation and pharmacological screening of chemical entities and biologicals | |
BR0016066A (en) | Compounds and methods for treatment and diagnosis of chlamydial infection | |
DE69737628D1 (en) | NUCLEIC ACID PRIMERS AND SENSORS FOR DETECTING ONCOCKEN HUMAN PAPILLOMA VIRUSES | |
CN104846122A (en) | Nucleic acid detection kit of enterovirus type 71 (EV71) and coxsackievirus type A16 (CA16) (fluorescent polymerase chain reaction (PCR) method) | |
DE69815370D1 (en) | FLUORESCEND CONJUGATES OF NUCLEOSIDES AND NUCLEOTIDES, THEIR METHOD FOR THE PRODUCTION AND THEIR USE | |
Gerken et al. | Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA | |
Lozano et al. | A simple nucleic acid amplification assay for the rapid detection of Junin virus in whole blood samples | |
AU2283792A (en) | Direct detection of hepatitis c virus rna | |
Huang et al. | An internal amplification control for quantitative nucleic acid analysis using nanoparticle-based dipstickbiosensors | |
Takkenberg et al. | Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients | |
FR2791357B1 (en) | WHIPPLE DISEASE DIAGNOSIS | |
WO2003061831A3 (en) | Sampling device and method for the simultaneous, quantifiable determination of infectious germs | |
BR9605926A (en) | Use of a viral and retroviral material from a nucleotide fragment of an indicator specific to a probe of a pathogen and / or infectious agent from an association of nucleotide fragments to obtain a first pathogen and / or infectious indicator specific to the amplification by plimerization of rna or dna of a viral material and probe susceptible to hybridize specifically with rna or dna of a viral material | |
Akanni et al. | Molecular diagnosis of hemoglobinopathies using allele-specific polymerase chain reaction in Nigeria | |
Bigogno et al. | The genetic landscape of hepatitis delta virus infection | |
Hazart | Angiostrongilosi con emorragia cerebrale in un cane. | |
Sharma et al. | Real time PCR usage in the quantification of hepatitis B virus DNA–clinical applications in disease management | |
Ezaki | DNA probes and the diagnosis of infectious diseases. | |
Shattock | Development of a gene probe assay suitable for use in routine diagnosis: a pilot study using a DNA probe for parvovirus B19 | |
Hasebe et al. | Diagnosis of type C chronic hepatitis using PCR technology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 4A, 5A, 6A E 7A ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007. |